The aim of this study was the elaboration of a basic voice protocol to discover which combination of tests and measures (multidimensional evaluation) provide decisive and essential data for the diagnosis of voice pathology and its prognosis. Voices of 21 patients with dysphonia and 21 subjects in a control group were evaluated and compared. Vocal function was assessed using a multiparametric set of videolaryngostroboscopic, perceptual, acoustic, spectrographic, aerodynamic, and subjective basic measurements (Multidimensional "Teatinos" Protocol). The dysphonic group received voice therapy for two sessions/week during 3 months. The results of the study were the following-(1) alterations in vocal function were reflected in the indicators: maximum phonation time (MPT) /a/, maximum exhalation time (MET) /s/, MPT during connect speech (MPTS), jitter, shimmer, harmonic-to-noise ratio, vocal well being (WB), self-voice assessment (SELF), vocal hygiene (HYGIENE), anxiety (ANX) and perceptual, laryngoscopic, and spectrographic explorations; (2) the indicators which are most sensitive to voice therapy are the following: MPT /a/, MET /s/, MPTS, jitter, WB, SELF, HYGIENE, ANX and perceptual, laryngoscopic, and spectrographic explorations; and (3) these positive effects were maintained or increased 4 months after termination of the treatment. Multidimensional "Teatinos" Protocol makes it possible to detect significant differences in mean values of subjective, qualitative, and objective voice assessments between dysphonic patients and control group at pre- and posttreatment stages. Therefore, multidimensional voice evaluation is a useful tool in the diagnostics of dysphonia in clinical and speech-language-therapy contexts.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jvoice.2007.05.001 | DOI Listing |
BMJ Case Rep
January 2025
Maxillofacial Surgery, Waikato Hospital, Hamilton, New Zealand.
A man in his late 50s was referred by a speech and language therapist for consideration of a palatal lift prosthesis (PLP) to improve his speech intelligibility. He presented with hypokinetic dysarthria characterised by reduced loudness, breathy voice and hypernasality. The patient had a diagnosis of progressive muscular dystrophy and mobilised in a motorised wheelchair.
View Article and Find Full Text PDFPatient
January 2025
Pfizer, New York City, NY, USA.
Using patient preference information (PPI) to incorporate patient voices into the drug development lifecycle can help align therapies with the needs and values of patients. However, several barriers have limited the use of PPI, including a lack of clarity on its use by decision-makers, a need for greater decision-maker trust in PPI, and a lack of time, budgets, and access to specialist expertise. The value proposition for PPI could be enhanced by making it FAIR: Findable, Accessible, Interoperable, and Reusable.
View Article and Find Full Text PDFThis case emphasizes iron deficiency anemia (IDA) as a potential risk factor for pulmonary embolism (PE), especially in patients with type 2 diabetes. Early recognition and management of PE and IDA are crucial. Further research is needed to clarify the mechanisms linking IDA to thrombosis and improve prevention strategies.
View Article and Find Full Text PDFPak J Med Sci
January 2025
Dr. Ayesha Babar Kawish, MSPH Al-Shifa School of Public Health, Al-Shifa Trust, Rawalpindi, Pakistan.
Background & Objectives: Poor medication adherence is an essential contributor to Pakistan's high prevalence of uncontrolled hypertension. This study will be aimed to assess the efficacy of a one-of-a-kind developed intervention in improving medication adherence and treatment outcomes in hypertension patients.
Methods: Twleve months duration long randomized controlled trial from January to December 2021 will be carried out at Shaikh Zayed Medical Complex (SZMC), Lahore.
J Voice
January 2025
Department of Speech and Language Therapy, School of Health Rehabilitation Sciences, University of Patras, Patras, Greece; A' ENT University Clinic, Medical School, National Kapodistreian University of Athens, Athens, Greece. Electronic address:
Objectives: The Singing Voice Handicap Index (SVHI) was culturally adapted and validated in Greek to examine the impacts of voice problems on a singer's everyday life.
Methods: The translated version was administered to 120 singers in total, along with the translated version of the Voice Handicap Index (VHI), a sort voice history questionnaire, two Self-Rating Dysphonia Severity Scales (SRDSSs), and two visual analog scales. A week after the original completion of the Greek version of SVHI, a second copy of the SVHI was administered to 50% of the participants.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!